BR0008214A - Processos para tratar cosmeticamente a pelepela mediação da comunicação célula a célula napele, e para o tratamento da pele para produzirbenefìcios de anti-envelhecimento e/ounormalização da pele, e, composição tópica - Google Patents

Processos para tratar cosmeticamente a pelepela mediação da comunicação célula a célula napele, e para o tratamento da pele para produzirbenefìcios de anti-envelhecimento e/ounormalização da pele, e, composição tópica

Info

Publication number
BR0008214A
BR0008214A BR0008214-7A BR0008214A BR0008214A BR 0008214 A BR0008214 A BR 0008214A BR 0008214 A BR0008214 A BR 0008214A BR 0008214 A BR0008214 A BR 0008214A
Authority
BR
Brazil
Prior art keywords
skin
cell
treating skin
aging
processes
Prior art date
Application number
BR0008214-7A
Other languages
English (en)
Inventor
Glen T Anderson
Dmitri S Ptchelintsev
Gopinathan K Menon
Ohn A Dufffy
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of BR0008214A publication Critical patent/BR0008214A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PROCESSOS PARA TRATAR COSMETICAMENTE A PELEPELA MEDIAçãO DA COMUNICAçãO CéLULA A CéLULA NAPELE, E PARA O TRATAMENTO DA PELE PARA PRODUZIRBENEFìCIOS DE ANTI-ENVELHECIMENTO E/OUNORMALIZAçãO DA PELE, E, COMPOSIçãO TóPICA." Estãodivulgadas composições para o tratamento da pele contendocompostos de sinalização de célula os quais induzem e promovema biossíntese e/ou a bioatividade de produtos químicosendógenos que mediam a comunicação de célula a célula na peleentre queratinócitos, fibroblastos e outros tipos de célulaspresentes na pele. O composto de sinalização de célula éselecionado do grupo que consiste de andrografolida e seusderivados; adenosina cíclica fosfato e seus derivados, proteínasde leite hidrolisadas; extrato de semente de girassol; extrato deplancton; fitol e seus derivados; e misturas dos mesmos.
BR0008214-7A 1999-12-14 2000-12-14 Processos para tratar cosmeticamente a pelepela mediação da comunicação célula a célula napele, e para o tratamento da pele para produzirbenefìcios de anti-envelhecimento e/ounormalização da pele, e, composição tópica BR0008214A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46144999A 1999-12-14 1999-12-14
US19098800P 2000-03-21 2000-03-21
PCT/US2000/033776 WO2001043704A1 (en) 1999-12-14 2000-12-14 A skin care composition that mediates cell to cell communication

Publications (1)

Publication Number Publication Date
BR0008214A true BR0008214A (pt) 2001-10-30

Family

ID=26886624

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008214-7A BR0008214A (pt) 1999-12-14 2000-12-14 Processos para tratar cosmeticamente a pelepela mediação da comunicação célula a célula napele, e para o tratamento da pele para produzirbenefìcios de anti-envelhecimento e/ounormalização da pele, e, composição tópica

Country Status (14)

Country Link
US (3) US20020006383A1 (pt)
EP (1) EP1152731B1 (pt)
JP (2) JP2003516950A (pt)
CN (1) CN100366248C (pt)
AR (1) AR027195A1 (pt)
AU (1) AU774676B2 (pt)
BR (1) BR0008214A (pt)
CA (1) CA2364300C (pt)
DE (1) DE60031836T2 (pt)
HK (1) HK1042044B (pt)
MX (1) MXPA01006553A (pt)
PL (1) PL201625B1 (pt)
TW (1) TWI281413B (pt)
WO (1) WO2001043704A1 (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001256570A1 (en) * 2000-05-05 2001-11-20 Dr. Reddy's Research Foundation Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them
CN1325056C (zh) * 2002-05-20 2007-07-11 大塚制药株式会社 用于改善黑斑病的组合物以及用于减轻肌肤黯淡的组合物
FR2847470B1 (fr) * 2002-11-26 2004-12-31 Oreal Composition, notamment cosmetique, comprenant l'adenosine et des sels de magnesium et potassium
FR2847469B1 (fr) * 2002-11-26 2006-04-07 Oreal Utilisation de l'adenosine ou d'un analogue d'adenosine, pour lisser les rides d'expression
FR2849377B1 (fr) * 2002-12-30 2007-08-03 Jean Noel Thorel Composition cosmetique, regulatrice de la flore cutanee
FR2849376B1 (fr) * 2002-12-30 2007-07-13 Jean Noel Thorel Composition cosmetique comprenant un complexe actif constitue d'au moins un peptide ou une proteine et au moins un nucleotide, polynucleotide ou acide nucleique
US9114156B2 (en) * 2002-12-30 2015-08-25 Aplicare, Inc. Enhanced antimicrobial skin preparation
CN100408571C (zh) * 2003-02-25 2008-08-06 北京医工生物技术研究所 穿心莲内酯三马来酸半酯及其盐和它们的药物组合物
DE10324256B4 (de) 2003-05-28 2010-04-22 Merz Pharma Gmbh & Co. Kgaa Lipid-Tranferprotein-Systeme und deren kosmetische/dermatologische Anwendung
DE10355743A1 (de) † 2003-11-28 2005-07-07 Wella Ag Verwendung von Peptiden zum Schutz der Haut vor Haarbehandlungsmitteln
JP2005179286A (ja) * 2003-12-22 2005-07-07 Nikko Chemical Co Ltd ヒアルロン合成促進剤の皮膚老化防止剤への利用
DE102004020060B3 (de) * 2004-04-20 2005-06-02 Coty B.V. Kosmetisches Verfahren zur Behandlung der Haut mit Sonnenprodukten und Sonnenprodukt-Kombination
FR2877218B1 (fr) * 2004-11-04 2007-02-09 Jean Noel Thorel Composition dermocosmetique destinee a repondre aux troubles de la pigmentation
US7453077B2 (en) * 2005-11-05 2008-11-18 Cymer, Inc. EUV light source
JP2007176934A (ja) * 2005-11-30 2007-07-12 Kose Corp 血小板活性化因子アセチルヒドロラーゼ機能調整剤
US20070160696A1 (en) * 2006-01-11 2007-07-12 The Procter & Gamble Company Compositions and methods useful for prevention or treatment of respiratory illness
US20070183995A1 (en) * 2006-02-09 2007-08-09 Conopco, Inc., D/B/A Unilever Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
FR2899584B1 (fr) * 2006-04-11 2008-05-16 Oreal Composition cosmetique antirides
US20120070473A1 (en) * 2007-08-17 2012-03-22 Anhese Llc Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions
WO2009127058A1 (en) * 2008-04-15 2009-10-22 Immanence Integrale Dermo Correction Inc. Skin care compositions and methods of use thereof
CA2728955C (en) * 2008-06-24 2013-03-19 Masamichi Muto Diluting solution for suspension for use in the measurement of number of living microbial cells contained in sample, and method for measurement of number of living microbial cells
US20100129299A1 (en) * 2008-11-21 2010-05-27 Singleton Laura C Topical sunscreen compositions for mitigating effects on intracellular ion concentration
US20100260695A1 (en) * 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
KR20130057969A (ko) * 2010-02-22 2013-06-03 에쥐 세라피틱스, 인코포레이티드 뇌의 출혈성 병상을 치료하기 위한 방법 및 조성물
EP2568814A4 (en) * 2010-05-14 2013-12-04 James J Messina BROTH SPECTRUM HARMFUL ANTI-ANIMAL ANTI-ANIMAL COMPOSITIONS AND PEST CONTROL SYSTEM
WO2011162416A1 (en) * 2010-06-25 2011-12-29 Otsuka Pharmaceutical Co., Ltd. Agent for suppressing the formation of abnormal skin cells caused by exposure to light
US8795640B2 (en) 2011-12-22 2014-08-05 Mary Kay Inc. Lip formulation
WO2013149323A1 (en) * 2012-04-02 2013-10-10 Ntegrity Natural products for skin care
JP2015514769A (ja) * 2012-04-20 2015-05-21 ザ プロクター アンド ギャンブルカンパニー 顔の毛穴の外観を改善するための組成物及び方法
WO2015117957A1 (en) * 2014-02-07 2015-08-13 Unilever N.V. A topical composition
US9913799B2 (en) 2014-07-11 2018-03-13 Mary Kay Inc. Cosmetic compositions and methods of their use
WO2016124306A1 (de) * 2015-02-02 2016-08-11 Merck Patent Gmbh Puderformulierung enthaltend insektenabwehrmittel
BR112017019054B1 (pt) * 2015-03-05 2021-05-11 Avon Products, Inc método cosmético, não terapêutico, para diminuir sinais dermatológicos de envelhecimento em pele humana e produtos para cuidados com a pele
US10076479B1 (en) 2018-05-08 2018-09-18 Avon Products, Inc. Methods for treating skin
CN105380849A (zh) * 2015-11-25 2016-03-09 陕西艾美雅生物科技有限公司 一种化妆品及其使用方法
CN105380848A (zh) * 2015-11-25 2016-03-09 陕西艾美雅生物科技有限公司 一种组合物及其制备方法、含有该组合物的化妆品及其使用方法
CN109646672A (zh) * 2019-01-10 2019-04-19 石家庄正扬头道生物科技有限公司 一种stm乌发药剂
FR3110573B1 (fr) * 2020-05-20 2024-01-19 Exsymol Sa Compositions comprenant des composés organo-silanols, et applications.
CN114795996B (zh) * 2022-04-08 2023-08-29 广东先强药业有限公司 一种含有核苷类成分的组合物及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1467955A1 (de) * 1964-05-12 1969-02-06 Hugo Janistyn Kosmetische Zubereitung von Phytol und/oder Phytolderivaten
US3978213A (en) * 1972-07-10 1976-08-31 Nelson Research & Development Company Cosmetic use of cyclic amp and phosphodiesterase inhibitors
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
DE3035022A1 (de) * 1980-09-17 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung und reinigung von phenoxyazolyl-butanon-derivaten
DE3201511A1 (de) * 1982-01-20 1983-07-28 Henkel Kgaa Sebosuppressive kosmetische mittel, welche laengerkettige alkanole und antioxidantien enthalten
FR2557452B1 (fr) 1983-12-28 1986-08-14 Roussel Uclaf Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate
JPS61178908A (ja) * 1984-02-27 1986-08-11 Kanebo Ltd 皮膚化粧料
US5686489A (en) * 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US5126376A (en) * 1988-06-24 1992-06-30 Stephen Herman Method for treating viral infection using topical administration
FR2657256B1 (fr) 1990-01-24 1994-09-16 Claude Bonne Nouvelles preparations cosmetiques contenant un extrait de tourteaux de tournesol (helianthus annuus).
US5262552A (en) * 1990-02-20 1993-11-16 Asahi Denka Kogyo K.K. Optically active compounds and intermediates thereof, and process for manufacturing same
JP2895572B2 (ja) 1990-05-18 1999-05-24 森永乳業株式会社 化粧料及び皮膚外用剤
DE69127020T2 (de) * 1990-05-18 1998-01-29 Morinaga Milk Industry Co Ltd Milchproteinhydrolysate und Zusammensetzungen zur Verwendung als Haar- und Hautbehandlungsmittel
WO1992004420A1 (en) * 1990-08-31 1992-03-19 Dainippon Ink & Chemicals, Inc. Antioxidizing composition and composition containing the same
EP0510165B1 (fr) * 1990-11-14 1995-01-25 L'oreal Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes
FR2687314A1 (fr) * 1992-02-18 1993-08-20 Oreal Dispersion de vesicules lipidiques, composition cosmetique et/ou pharmaceutique la contenant et procede de preparation de ladite dispersion.
US5741518A (en) * 1992-08-03 1998-04-21 L'oreal Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids
JP3080797B2 (ja) 1992-12-01 2000-08-28 ポーラ化成工業株式会社 ペプチドを含有する化粧料
US5484597A (en) * 1993-07-30 1996-01-16 Chesebrough-Pond's Usa Co. Clear hydroalcholic cosmetic microemulsions
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US5541225A (en) * 1994-10-11 1996-07-30 The General Hospital Corporation α-Linolenic acid and eicosatetraynoic acid in the prevention and treatment of ventricular tachyarrhythmia
AU4376396A (en) * 1994-12-06 1996-06-26 Paracelsian, Inc. Use of andrographolide compounds to treat or prevent pathogenicity of diseases
JPH0930946A (ja) * 1995-07-21 1997-02-04 Shiseido Co Ltd 美白用皮膚外用剤
GB9602111D0 (en) * 1996-02-02 1996-04-03 Unilever Plc Personal care composition
JPH1029927A (ja) 1996-07-12 1998-02-03 Shiseido Co Ltd 抗老化剤
JPH10114648A (ja) 1996-10-11 1998-05-06 Kao Corp 皮膚外用組成物
JPH10167957A (ja) 1996-12-09 1998-06-23 Kao Corp 細胞間接着抑制剤
DE19804837A1 (de) * 1998-01-29 1999-08-05 Coty Bv Kosmetisches Produkt zur Regenerierung und Stimulierung der Hautzellen

Also Published As

Publication number Publication date
EP1152731A4 (en) 2002-10-30
US20030035819A1 (en) 2003-02-20
PL201625B1 (pl) 2009-04-30
TWI281413B (en) 2007-05-21
US20020006383A1 (en) 2002-01-17
DE60031836T2 (de) 2007-06-28
CA2364300C (en) 2012-10-16
HK1042044A1 (en) 2002-08-02
CA2364300A1 (en) 2001-06-21
PL349174A1 (en) 2002-07-01
AU2094601A (en) 2001-06-25
EP1152731B1 (en) 2006-11-15
JP2007191493A (ja) 2007-08-02
DE60031836D1 (de) 2006-12-28
AU774676B2 (en) 2004-07-01
US7960437B2 (en) 2011-06-14
US20050129723A1 (en) 2005-06-16
JP2003516950A (ja) 2003-05-20
MXPA01006553A (es) 2002-03-14
CN1364073A (zh) 2002-08-14
EP1152731A1 (en) 2001-11-14
WO2001043704A8 (en) 2001-10-04
WO2001043704A1 (en) 2001-06-21
AR027195A1 (es) 2003-03-19
JP4658994B2 (ja) 2011-03-23
CN100366248C (zh) 2008-02-06
HK1042044B (zh) 2007-06-08

Similar Documents

Publication Publication Date Title
BR0008214A (pt) Processos para tratar cosmeticamente a pelepela mediação da comunicação célula a célula napele, e para o tratamento da pele para produzirbenefìcios de anti-envelhecimento e/ounormalização da pele, e, composição tópica
Limtrakul et al. Anti-aging and tyrosinase inhibition effects of Cassia fistula flower butanolic extract
Desmarchelier et al. Evaluation of the in vitro antioxidant activity in extracts of Uncaria tomentosa (Willd.) DC.
KR20090056910A (ko) 아스코르브산 2-글루코사이드 및 에르고티오네인을 포함하는 화장용 조성물
US20050208160A1 (en) Activities of an active principle obtained from powdered alfalfa seeds (medicago sativa) , active principle used and process of obtaining the same
Im et al. Protective effect of fermented Cyclopia intermedia against UVB-induced damage in HaCaT human keratinocytes
JP2018537455A (ja) 低分子ｒｎａオニユリ抽出物を含む局所組成物および加齢に関する皮膚の徴候を低減するための美容ケア方法
US6689349B1 (en) Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
ATE67667T1 (de) Neue topische metronidazol-formulierungen.
Kim et al. Protective effects of ginseng leaf extract using enzymatic extraction against oxidative damage of UVA-irradiated human keratinocytes
Vora et al. Protective effects of Petroselinum crispum (Mill) Nyman ex AW Hill leaf extract on D-galactose-induced oxidative stress in mouse brain
KR100253842B1 (ko) 멀베린을 함유하는 미백화장료
Barak et al. In vitro anti-aging potential evaluation of Maclura pomifera (Rafin.) Schneider 80% methanol extract with quantitative HPTLC analysis
Kim et al. Effect of 1, 2, 3, 4, 6-penta-O-galloyl-beta-D-glucose on elastase and hyaluronidase activities and its type II collagen expression
WO2013077569A1 (ko) 흰감국 추출물을 함유하는 피부 외용제 조성물
Pekmezci et al. Proprietary herbal extract downregulates the gene expression of IL-1α in HaCaT Cells: Possible implications against nonscarring alopecia
CN108619016A (zh) 清香木的美白及皱纹改善用途
KR100538866B1 (ko) 알로에신 유도체의 합성방법
CN115227616A (zh) 具有抗氧化作用的组合物、应用及化妆品
KR100866784B1 (ko) 개서어나무 잎 추출물을 포함하는 피부주름 개선용 화장료조성물
CN111870553B (zh) 化妆品美白剂、生物美白化妆品
BR0012033A (pt) Composição cosmética para cuidado da pele, e, processos cosméticos para tratamento da pele envelhecida, fotoenvelhecida, seca, com linhas ou enrugada, para melhorar a função de barreira da pele, para melhorar a diferenciação dos ceratinócitos, para melhorar a produção de lipìdios pelos ceratinócitos, para melhorar a captação de glicose pelos ceratinócitos, e para melhorar a captação de ascorbato pelos ceratinócitos
KR101398392B1 (ko) 가막살나무 추출물을 포함하는 피부주름 개선용 화장료조성물
KR19990030419A (ko) 자연산 상황버섯 추출물의 추출방법 및 그 추출물을 이용한 미백화장품 제조방법
RU2336890C2 (ru) Составы, содержащие мелатонин, ginkgo biloba и биотин

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 7/00; A61K 31/00; A61K 35/00; A61K 38/00.

Ipc: A61Q 19/08 (2006.01), A61K 8/34 (2006.01), A61K 8/

B11T Dismissal of application maintained [chapter 11.20 patent gazette]